On October 22, the US Treasury proposed adding biotechnology to the list of Chinese sectors that American capital may no longer finance. A week earlier, China’s Ministry of Commerce had proposed barring the foreign sale of five biomedical technologies, including cell and gene therapy platforms. Two governments that agree on almost nothing moved in the […]
